AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...

Insmed (INSM) announced that the U.S. FDA has accepted the company’s New Drug Application for brensocatib for patients with non-cystic fibrosis ...

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

An FDA-approved medication can now treat Friedreich's ataxia, but health plan barriers and formulary exclusions keep many patients from receiving it.

Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an ...

DelveInsight's Peptide-drug Conjugate Market Insights report provides the current and forecast market analysis, individual ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment LONDON, Feb. 4, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading ...

Comment by Feb. 17 for your feedback to be reviewed by the guideline development workgroup.

Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to ...

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs ...